Trials / Completed
CompletedNCT01779271
Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 183 (actual)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
Multi-center, Randomized, Double blind, Controlled Parallel-group Comparative Phase 3 Clinical trial to assess the efficacy and safety of Pelubiprofen Compared to Loxoprofen in patients with Acute upper respiratory infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pelubiprofen | |
| DRUG | Loxoprofen |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2016-03-01
- First posted
- 2013-01-30
- Last updated
- 2016-10-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01779271. Inclusion in this directory is not an endorsement.